Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2025-12-25 @ 9:26 PM
Study NCT ID:
NCT01194856
Status:
TERMINATED
Last Update Posted:
2017-08-11
First Post:
2010-09-02
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression
Sponsor:
The Cleveland Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-10
Start Date Type:
None
Primary Completion Date:
2011-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-12
Completion Date Type:
ACTUAL
First Submit Date:
2010-09-02
First Submit QC Date:
None
Study First Post Date:
2010-09-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-01-11
Results First Submit QC Date:
None
Results First Post Date:
2017-08-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-10
Last Update Post Date:
2017-08-11
Last Update Post Date Type:
ACTUAL